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ABSTRACT
Objectives: To evaluate a protocol for a population-
based programme targeting the prevention of
rheumatic heart disease (RHD) progression by early
echocardiographic diagnosis of valvular lesions and
timely implementation of secondary prevention.
Design: Observational survey with a subsequent
prospective cohort study.
Setting: Private boarding school in the urban area of
the Sunsari district situated on the foothills of the
Lower Himalayan Range in Eastern Nepal.
Participants: Fifty-four unselected school-going
children 5–15 years of age, 24 girls and 30 boys.
Primary outcome measure: Logistic feasibility of a
large-scale population-based screening study using the
echocardiographic criteria formulated by the World
Heart Federation, with longitudinal follow-up of
children with definite or borderline RHD in a
prospective cohort study.
Results: Standardised interview, physical examination
and screening echocardiography were performed in a
three-staged process and took approximately 6 min per
child. Socio-economic status was assessed using
surrogate markers such as the occupation of the
primary caregiver, numbers of rooms at home, car,
television, cell phone and internet connection. Physical
examination was focused on cardiac auscultation and
signs of acute rheumatic fever and targeted
echocardiography was performed by an independent
examiner without knowledge of the clinical findings.
Two children with evidence of borderline RHD were re-
examined at B.P. Koirala Institute of Health Sciences
and the indication for secondary antibiotic prevention
was discussed with the parents and the children. At
6 months of follow-up, echocardiographic findings
were stable in both children. Implementation of
secondary antibiotic prevention was challenged by
impaired awareness of subclinical RHD among parents
and inadequate cooperation with family physicians.
Conclusions: This pilot study shows that the methods
outlined in the protocol can be translated into a large-
scale population-based study. We learned that education
and collaboration with teachers, parents and family
physicians/paediatricians will be of key importance in
order to establish a sustainable programme.
INTRODUCTION
Rheumatic heart disease (RHD) is esti-
mated to affect more than 15 million
people worldwide and leads to 250 000
deaths every year.1 More than 80% of the
children younger than 15 years of age grow
up in regions of the world where RHD is
endemic.2 A discrepancy of reported preva-
lence rates of RHD among schoolchildren
in developing countries is particularly
attributable to diverse sensitivities of echo-
cardiographic and clinical screening,
respectively. RHD consolidates a spectrum
of different stages of clinically silent and
clinically manifest valvular degeneration
culminating in congestive heart failure,
increasing the risk of endocarditis, cerebro-
vascular events and eventually leading to
ARTICLE SUMMARY
Article focus
▪ Pilot study for a population-based programme
targeting prevention of rheumatic heart disease
(RHD) progression by early echocardiographic
diagnosis of valvular lesions and timely imple-
mentation of secondary prevention.
Key messages
▪ The echocardiographic criteria for diagnosis of
RHD provided by the World Heart Federation are
a valuable instrument for population-based
screening.
▪ Adequate information of the parents of children
with evidence of silent RHD and cooperation
with the family physicians is of key importance
for long-term adherence to secondary antibiotic
prevention.
Strengths and limitations of this study
▪ The pilot study demonstrates feasibility of a
large-scale population-based screening programme
for RHD by the use of portable echocardiography,
with a subsequent prospective cohort study.
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premature death of the affected working-age popula-
tion in developing countries.
Acute rheumatic fever (ARF) ensues from an auto-
immune reaction in response to group A β-haemolytic
streptococcal pharyngitis and may result in RHD
through the cumulative valvular damage of recurrent
episodes of ARF.2 Whereas overcrowding and poverty are
major determinants of disease proliferation, limited
access to healthcare resources renders primary preven-
tion with prompt antibiotic treatment of streptococcal
pharyngitis difficult to effectuate in large parts of
endemic regions of the world. Secondary prevention
among children with a documented history of ARF or
evidence of RHD is achieved by regular oral or intraven-
ous administration of penicillin continued until early
adulthood.
The WHO has recommended echocardiographic
screening of RHD in high-prevalence regions.3 Early
detection of subclinical RHD by use of echocardiog-
raphy warrants timely implementation of secondary anti-
biotic prophylaxis and may prevent progression of
valvular damage leading to congestive heart failure. We
performed a pilot study in order to test the feasibility
of a cross-sectional survey and a longitudinal cohort
study to assess prevalence and clinical outcome of RHD
according to the World Heart Federation criteria.4
AIMS AND OBJECTIVES
The goal of the project consists in the prevention of
RHD progression by early echocardiographic diagnosis
of valvular lesions and timely implementation of second-
ary prevention. We designed a study to investigate the
prevalence rate of definite and borderline RHD among
children in Eastern Nepal, and to assess long-term
clinical outcome of children undergoing secondary anti-
biotic prevention for RHD.5 The objective of the pilot
study was to evaluate the administrative and logistic feasi-
bility of a large-scale population-based screening study,
specifically pertaining to questionnaire design and
protocol adherence, and to assess the recruitment of
children with signs of RHD into a prospective cohort
with longitudinal follow-up.
METHODS
Study design and setting
The design of the study has been outlined in detail pre-
viously.5 In summary, a cross-sectional survey of school-
children aged 5–15 years will be performed for clinically
silent or manifest RHD in the Sunsari district of Eastern
Nepal. The location in rural or urban areas, as well as
public or private administration of the schools will be
used as a surrogate to reflect the socio-economic demo-
graphic distribution of the population in Eastern Nepal.
Children found to have signs consistent with RHD will
be enrolled in a prospective cohort to be followed over
the course of 5 years. The Sunsari district is situated on
the foothills of the Lower Himalayan Range in Eastern
Nepal and extends to the south of the city of Dharan,
the third-largest city in Nepal.
Study population
The selection of the school for the pilot study was
driven by practical reasons and was not based on a pre-
specified sampling procedure to obtain a representative
study population. As a consequence, the cohort of the
pilot study is not eligible for inclusion into the actual
study cohort.
A small private boarding school in the urban area of
the Sunsari district was selected. A discussion with the
principal of the school was performed in order to
outline the aim of the project and obtain informed
consent. All children of this particular school underwent
screening echocardiography.
Data collection
Data acquisition was organised in a three-staged process
by study nurses and physicians. School teachers orga-
nised the transfer of the children between the study
nurses and physicians gathering demographic char-
acteristics, performing physical examination and con-
ducting echocardiography, respectively. Data on social
background and medical history were acquired in a stan-
dardised interview on the basis of a questionnaire.
Demographic variables such as age, household charac-
teristics and socio-economic indicators were recorded
along with a short medical history followed by physical
examination documenting height, weight and potential
clinical signs of ARF. Study nurses questioned the chil-
dren about demographic characteristics, filled in the
questionnaire, and measured height and weight. A first
physician completed the medical history and executed
physical examination including cardiac auscultation.
A second independent physician performed screening
echocardiography using the Samsung portable U6 echo-
cardiography machine to document morphological
and/or functional valvular lesions consistent with RHD.
Parents of children with evidence of RHD were con-
tacted by the physicians and oriented about the findings.
The children and parents were subsequently invited for
a thorough examination at B.P. Koirala Institute of
Health Sciences. Follow-up data of children with border-
line or definite RHD was collected during a dedicated
follow-up visit 6 months after screening.
All data were documented on dedicated paper case
report forms that were subsequently transferred into an
electronic database.
Definitions
RHD was classified in accordance with the WHF criteria
for individuals aged ≤20 years into definite and border-
line.4 Definite RHD was divided into four subcategories.
Subcategory A is defined by pathological mitral regurgita-
tion and at least two morphological features of RHD of the
mitral valve, subcategory B is diagnosed in the presence of
mitral stenosis with a mean gradient of ≥4 mmHg.
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Subcategory C is characterised by pathological aortic
regurgitation in combination with at least two morpho-
logical features of RHD of the aortic valve, and subcat-
egory D is determined by borderline disease of both the
aortic valve and the mitral valve. Borderline RHD is parti-
tioned into three subcategories. Subcategory A is deter-
mined by the presence of at least two morphological
features of RHD of the mitral valve without pathological
mitral regurgitation or mitral stenosis, subcategories B
and C are characterised by pathological mitral regurgita-
tion, or pathological aortic regurgitation, respectively.
Physiological mitral regurgitation (A), physiological aortic
regurgitation (B) and an isolated morphological feature of
RHD of the mitral or aortic valve (ie, valvular thickening)
without any associated pathological stenosis or regurgita-
tion (C and D, respectively) are classified as normal echo-
cardiographic findings.
Ethics and funding
The study was conducted in compliance with the declar-
ation of Helsinki and was registered with clinical trials.gov
(NCT01550068). The study was approved by the ethic
committee of B.P. Koirala Institute of Health Sciences
and was given an exempt status by the ethics committee
at University of Bern, Switzerland (KEK-BE 018/12). The
pilot study was supported by an unrestricted grant
from the foundation ‘Coeur de la Tour’ (http://www.
coeurdelatour.ch) from Geneva, Switzerland.
Sample size calculation
Sample size was determined by practical aspects rather
than estimations of prevalence rates. In order to
adequately evaluate the questionnaires and assess the
duration of a screening examination, we considered a
mixed cohort of schoolchildren across all age groups
important. We considerably selected a private school
with a small number of students in order to allow screen-
ing of all children from the selected school in a single
day. The localisation of the school in an urban area of
the lower-middle class with only limited access to electri-
city throughout the hours of the day simulated a chal-
lenge often encountered in more rural areas of Eastern
Nepal. The screening examinations were timed and per-
formed in a single afternoon.
Statistical analysis
Statistical analyses were performed using SPSS
Statistics V.17.0. Continuous variables are presented as
mean±SD. Categorical data are expressed as frequency
(percentages).
RESULTS
Observational survey
Fifty-four children from a private boarding school in the
urban area of the Sunsari district ranging from 5 to
15 years of age were included in the pilot observational
survey, which was performed by two cardiologists, a
paediatrician, an internal medicine resident and two
nurses. Screening was scheduled for a single afternoon
on a regular school day. Standardised interview, physical
examination and screening echocardiography were per-
formed in a three-staged process and took all together
approximately 6 min per child. Screening examinations
for this pilot study were performed in two dedicated
rooms, one for interview and physical examinations and
another one for echocardiography. Boys and girls were
examined separately; cardiac auscultation of girls was
performed by a female or a male doctor in the presence
of a female chaperone. Teachers ensured the efficient
realisation of the screening process and engaged chil-
dren waiting to be examined.
Socio-economic status was evaluated using specific
questions addressing surrogate markers such as the occu-
pation of the primary caregiver, numbers of rooms at
home, car, television, cell phone and internet connec-
tion. These questions were readily answered by the
majority of the children irrespective of age. Most of the
children were belonging to lower middle-class families,
where the primary caregiver was a manual worker, five
family members were living in three rooms, owned a
television and cell phone, but had no car and no inter-
net connection at home (table 1). In turn, questions
pertaining to a documented history of a previous attack
of rheumatic fever had to be addressed using approxi-
mative closed questions about regular medication
intake, hospitalisations or prolonged disease in the past,
and joint pain. No verification with parents or medical
documentation was performed.
Physical examination documented height and weight,
and was focused on cardiac auscultation and signs of
acute rheumatic fever. Mean age was 9.6±2.6 years,
and 56% of the children were boys. Cardiac
auscultation revealed four children with soft systolic
heart murmurs.
Targeted echocardiography was performed by an inde-
pendent examiner without knowledge of the clinical
Table 1 Pilot study baseline characteristics
Baseline characteristics n (%) or mean (SD)
Age (years) 9.6 (2.9)
Height in (cm) 127 (16)
Weight in (kg) 28 (12)
Male 30 (55.6)
Documented history of ARF 0 (0)
Socio-economic status
Number of family members 4.9 (1.2)
Children 2.2 (0.9)
Adults 2.6 (1.0)
Amenities at home
Household, Number of rooms 2.8 (1.6)
Family owns a car 1 (1.9)
Television at home 50 (92.6)
Internet connection at home 4 (7.7)
Family uses a cell phone 51 (94.4)
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findings. While none of the children had echocardio-
graphic evidence of definite RHD, two children were
found to have borderline RHD, and two children had
isolated thickening of the anterior mitral valve leaflet
without pathological regurgitation, which did not meet
the criteria for borderline RHD according to the WHF
criteria. A 12-year-old asymptomatic boy with no history
of ARF and a soft systolic heart murmur was found to
have significant thickening of the anterior mitral valve
leaflet associated with pathological mitral regurgitation
and mild tricuspid regurgitation. Another asymptomatic
12-year-old boy with a soft systolic heart murmur had
restricted posterior mitral valve leaflet motion with evi-
dence of pathological mitral regurgitation and mild tri-
cuspid regurgitation. During a subsequent outpatient
visit at B.P. Koirala Institute of Health Sciences, the indi-
cation for secondary antibiotic prevention was discussed
with the parents and the children, and orientation for
inclusion into a prospective registry was provided.
Barriers to implementation of the observational survey
included limited electricity supply around the clock and
unpredictable power cuts rendering a battery-operated
portable echocardiography machine indispensable.
The selection process of schools that adequately
reflect the demographic distribution of the target area
was outlined previously and was not assessed in the
present pilot study.5
Longitudinal follow-up
Both children with evidence of borderline RHD are
being prospectively followed up and have been invited
for a clinical and echocardiographic follow-up examin-
ation at 6 months after screening. None of the children
had experienced an adverse event and echocardio-
graphic findings were stable as compared with baseline
in both kids.
Secondary antibiotic prevention was discontinued in
both children within the first 6 months of follow-up. The
family physicians who had not been involved in the
initial decision for initiation of prevention had recom-
mended against prolonged antibiotic treatment in the
absence of pathological heart murmurs and no docu-
mented attacks of rheumatic fever.
Implementation of secondary antibiotic prevention
was challenged by impaired understanding of subclinical
RHD among parents and family physicians/paediatri-
cians. Limited public awareness and education, as well as
inadequate collaboration with family physicians emerged
as barriers to compliance with secondary prevention.
DISCUSSION
We report the results of a pilot study evaluating a
research protocol for an observational survey of RHD
among school-going children and a subsequent pro-
spective cohort study of children with evidence of
rheumatic valvular lesions. This pilot study represents an
integral part for the final implementation of the
protocol in a large population-based setting. The main
findings can be summarised as follows:
1. Clinical and echocardiographic screening of RHD is
feasible within 5–10 min per child. Active involve-
ment of the teachers who are familiar with the chil-
dren not only facilitates the organisation but also
anticipates distrust towards medical personnel from
both children and teachers.
2. Adequate orientation of and collaboration with the
parents after diagnosis of RHD in a child is of key
importance to adherence to preventive antibiotic treat-
ment. Accepting the diagnosis of subclinical RHD in
an apparently healthy child is difficult for both the
parents and the children and calls for continued
support.
3. Collaboration with family physicians and paediatri-
cians is important to improve adherence to second-
ary prevention for clinically silent RHD. Inconsistent
information causes insecurity and decreases the
motivation for compliance with regular antibiotic
prevention.
4. The WHF criteria are a helpful instrument to classify
subclinical valvular lesions consistent with RHD.
We learned from this pilot study, that collaboration
with teachers, parents and family physicians/pasediatri-
cians is indispensable to perform efficient screening,
improve compliance with secondary prevention and
ascertain clinical follow-up.
Informed teachers were allies in our study not only in
terms of facilitating the organisation of the pilot study,
but also with regard to the orientation of the parents of
the two children diagnosed with clinically silent RHD.
Moreover, completion of parts of the questionnaire
asking for socio-economic background could be assisted
by the teachers and would improve quality of the data.
As a consequence we plan to extend the participation of
the teachers in the collection of the baseline criteria in
the main study.
In addition to the school teachers, the parents of the
children will be the key players for successful completion
of the programme. Accepting disease in an asymptom-
atic child is difficult for every parent. Continued educa-
tion during every clinical visit with adequate cultural
sensitivity should reinforce adherence to treatment.
Given the high illiteracy rate in Nepal, information bro-
chures distributed to the parents will not achieve the tar-
geted objective. In response to the need for education
on RHD diagnosis and prevention, we are therefore pre-
paring a documentary film that will be broadcasted on
local television and in schools before the screening
examinations begin.
Collaboration with family physicians and paedia-
tricians will be central to improve long-term adher-
ence to secondary antibiotic prevention for silent
RHD. Inconsistent information will cause insecurity
among parents and children and decrease the motiv-
ation for compliance with regular antibiotic
prevention. Continuing education will be provided to
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family physicians in the area in order to enhance
collaboration and coordinate recommendations on
secondary prevention.
Previous studies using primary screening echocardiog-
raphy performed in endemic regions in Southeast
Asia,6–8 the Western Pacific,9 10 Africa6 11 and Central
America12 reported prevalence rates of RHD among
children ranging from 20.4/1000 to 55.2/000 children
most of which using the 2006 WHO criteria. In contrast
to the WHO criteria combining both, clinical and echo-
cardiographic findings, the WHF criteria are based on
echocardiographic criteria only, and have been applied
for the present pilot study.3 4 Studies documenting echo-
cardiographic follow-up reported stable disease or even
regression of valvular lesions in three quarters of the
children, but were mainly limited by a short duration of
follow-up and a small sample size.7 8 12
The recently released WHF criteria for echocardio-
graphic diagnosis of RHD proved helpful in the classifi-
cation of valvular lesions related to subclinical RHD and
provide an adequate instrument for large population-
based studies.
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